Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502813 · ClinicalTrials.gov registry record · NA
Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
A NA study of Cognitive Benefits, sponsored by Deborah Yurgelun-Todd.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01502813 is a NA study of Cognitive Benefits that has completed, run by Deborah Yurgelun-Todd. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01502813, a NA study of Cognitive Benefits, has completed, sponsored by Deborah Yurgelun-Todd.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.
Conditions Studied
Interventions
- DRUG Citicoline, Omega-3 Fatty Acids and Creatine
Study Locations (1)
Utah
- The Brain Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-02-01 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01502813
The ClinicalTrials.gov registry entry for NCT01502813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Deborah Yurgelun-Todd, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognitive Benefits appearing as the primary indexed condition, and to 1 intervention - of which Citicoline, Omega-3 Fatty Acids and Creatine is the first listed.
NCT01502813 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT01502813 about?
NCT01502813 is a clinical study titled "Citicoline, Creatine, and Omega-3 Effects in Middle Age Women". The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.
What is the current status of trial NCT01502813?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-02-01. Estimated completion is 2019-11-01.
What conditions does trial NCT01502813 study?
This clinical trial studies the following conditions: Cognitive Benefits.
What interventions are being tested in trial NCT01502813?
The interventions under investigation include: Citicoline, Omega-3 Fatty Acids and Creatine (DRUG).
Who is sponsoring clinical trial NCT01502813?
This trial is sponsored by Deborah Yurgelun-Todd, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01502813 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.